This prospective, observational study explores the role of platelet function testing in optimizing the management of patients undergoing coronary artery bypass grafting (CABG).
By assessing platelet reactivity in the postoperative period, the study aims to determine whether individualized antiplatelet therapy can improve graft outcomes, reduce complications, and enhance overall recovery. The findings are intended to support more targeted, evidence-based antiplatelet management strategies following CABG surgery.
